BNTC
Benitec Biopharma Ltd
9.00$
-6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | |
| – | 263.2% | – | 324.2% | 950.0% | 766.7% | 1,015.1% | 704.9% | 359.7% | 32.3% | 3.7% | 3.7% | 30.0% | 81.7% | 10.8% | 3.6% | -190.7% | 208.5% | 12.3% | 508.0% | 158.8% | – | – | |
| – | -163.2% | 100.0% | -224.2% | -850.0% | -666.7% | -915.1% | -604.9% | -259.7% | 67.7% | 96.3% | 96.3% | 70.0% | 18.3% | 89.7% | 91.1% | 290.7% | -108.5% | 87.7% | 100.0% | -158.8% | – | – | |
| 1,096.8% | 574.0% | 93.1% | – | 207.1% | 481.5% | 801.4% | 817.0% | 404.6% | 628.4% | 576.1% | 576.1% | 2,863.6% | 2,079.6% | 84.7% | 18.3% | 3,093.8% | 11,898.3% | 15,441.1% | 17,032.0% | 7,226.4% | – | – | |
| – | – | – | – | – | – | – | – | – | 803.5% | 753.2% | 744.2% | 2,523.9% | 2,731.5% | 107.2% | 18.5% | 5,739.2% | 11,037.3% | 9,104.1% | 8,509.3% | 3,235.6% | – | – | |
| 8,498.0% | 2,700.3% | 182.3% | 122.7% | 187.6% | 481.5% | 801.4% | 1,387.7% | 1,066.1% | 1,562.6% | 1,511.2% | 1,703.9% | 7,274.3% | 6,241.2% | 377.8% | 75.3% | 8,827.8% | 22,935.6% | 24,545.2% | 25,541.3% | 10,412.0% | – | – | |
| -9,311.0% | -2,788.5% | -82.3% | -346.9% | -1,037.6% | -1,148.2% | -1,716.5% | -1,992.6% | -1,325.9% | -1,494.9% | -1,414.9% | -1,607.6% | -7,204.2% | -8,132.4% | -198.4% | 21.2% | -8,537.1% | -23,044.1% | -24,457.5% | -25,441.3% | -10,412.0% | – | – | |
| 39.1% | 36.8% | – | 0.5% | 3.3% | 1.7% | 37.3% | 18.6% | 2.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 63.9% | 10.2% | 43.8% | 44.0% | 418.5% | – | – | |
| -8,507.7% | -1,346.9% | -21.4% | -498.9% | -965.5% | -1,095.4% | -3,069.9% | -2,255.8% | -1,271.0% | -1,253.0% | -1,064.7% | -1,064.7% | -5,340.1% | -1,708.7% | -194.3% | 21.4% | -8,529.9% | -23,528.8% | -24,942.5% | -26,082.7% | -10,069.9% | – | – | |
| – | – | – | – | – | -39.9% | – | – | – | -75.9% | -421.8% | 130.3% | -3,482.1% | -5,282.0% | -95.6% | -5.3% | 27.8% | -171.2% | 484.9% | 4.0% | -286.6% | – | – | |
| -8,507.7% | -2,689.8% | -331.8% | -682.3% | -965.5% | -1,055.5% | -3,069.9% | -2,255.8% | -1,271.0% | -766.8% | -718.2% | -1,064.7% | -5,340.1% | -2,860.4% | -280.1% | 21.4% | -8,529.9% | -23,528.8% | -24,942.5% | -26,082.7% | -10,069.9% | – | – | |
| -7,555.6% | -2,511.6% | -82.3% | -346.4% | -1,036.0% | -1,145.8% | -1,714.0% | -1,986.8% | -1,321.9% | -1,234.5% | -1,018.6% | -956.6% | -8,142.2% | -1,637.5% | -143.6% | 11.0% | -8,151.5% | -22,800.0% | -24,361.6% | -24,933.3% | -10,253.2% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.